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Introduction 
Aortofemoral prosthetic graft infection remains one of 
the most complex challenges that a vascular surgeon 
faces. Although the reported incidence of this serious 
complication is approximately 2%, the current pub- 
lished associated mortality and amputation rates range 
from 5 to 25%. 1-5 Multiple approaches to the resolution 
of this dreaded complication have been reported with 
each having advantages and disadvantages, as well as 
variable results among different investigators. The 
most accepted approach as been complete xcision 
of the infected prosthesis with extra-anatomic re- 
vascularisation, either in a simultaneous or staged 
fashion. 1'3'6'7 Recently, other innovative re- 
vascularisation techniques such as retroperitoneal 
in-line prosthetic grafts, s antibiotic-bonded prosthetic 
graft in situ replacement, 9q~ and in situ replacement 
with cryopreserved homografts have been published 
with good early and mid-term results. ~2 Although for 
infrainguinal prosthetic graft infections ome authors 
have proposed a conservative (no total excision) ap- 
proach, 13"14 most authors concur that in the presence 
of sepsis and total graft involvement, complete xcision 
and autogenous revascularisation provides the lowest 
morbidity and mortality. 1>17 
Extra-anatomic revascularisation with axillofemoral, 
femorofemoral prosthetic bypass has been the fre- 
quently used approach, either staged or simultaneous 
to replace an excised infected aortic graft. However, 
when the septic process involves the femoral vessels 
then the approach used to restore lower extrem!ty 
flow becomes more complex. The usual approach as 
been the use of bilateral axillo-deep femoral artery or 
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bilateral axillopopliteal bypass. Unfortunately, these 
two approaches are associated with early failure 
due to recurrent hrombosis of the extra-anatomic 
graft, lsa9 The use of autogenous tissue, such as sa- 
phenous vein, can be an attractive alternative for the 
crossover bypass graft in such cases, as it can be 
used in a contaminated bed as long as appropriate 
debridement, drainage and coverage of the ana- 
stomosis is performed. 1'2° Autogenous superficial fem- 
oral vein, with or without saphenous vein, can also 
be used to create a new aortoiliac system (NAIS) at 
the time the aortic graft is excised. This approach 
has two distinct advantages in that it avoids extra- 
anatomic revascularisation a d uses autogenous vein 
with its attendant bacterial resistance. This interesting 
approach has been reported to have excellent early 
results. 5'21"a2 Based on these encouraging results by 
other investigators, we report our experience with 
autogenous vein revascularisation of the lower ex- 
tremities in 16 patients with Staphylococcus aureus graft 
infections. 
Materials and Methods 
We reviewed the records of patients with S. aureus 
prosthetic graft infections from January 1990 through 
November 1995. The study group consisted of 14 men 
and two women with a mean age of 63 years (range 
26-89 years). All patients had the diagnosis of S. aureus 
graft infection made prio r to their reoperation. Two of 
the bacterial isolates were oxacillin-resistant S. aureus. 
In the aortic graft infection, aspiration of groin infection 
site for bacteriological evaluation was performed in 
five patients after computed tomography (CT) con- 
firmation of perigraft fluid. Two patients had as- 
piration of aortic perigraft fluid to confirm the septic 
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Fig. 1. Computerised tomography of patient with S. aureus sepsis 
48 months after aortobifemoral graft. Note the perigraft fluid whose 
percutaneous CT-guided aspiration grew S. aureus. 
process (Fig. 1). In the infrainguinal graft infection 
group, cultures of wound drainage provided the dia- 
gnosis of S. aureus graft infection. Two patients with 
aortic graft infections had a second bacterial isolate 
of Staphylococcus epidermidis (n=l)  and Enterobacter 
cloacae (n = 1), respectively. Seven patients (43.7%) had 
an aortobifemoral Dacron graft infection with a mean 
time of presentation f 18 months (range 1-48 months) 
(Table 1). Six (37.5%) patients had an infected femo- 
ropopliteal/distal PTFE graft with a mean time of 
presentation of 2.8 months (range 0.5-6 months). Two 
of the bacterial isolates were oxacillin-resistant S. 
aureus. Two patients presented with a crossover 
femorofemoral (PTFE) graft infection and an infected 
axillofemorofemoral (PTFE), respectively, with a mean 
time of presentation of 1.5 weeks. One patient was 
transferred toour hospital with an oxacillin-resistant S. 
aureus infection of an ipsilateral femorofemoral Dacron 
graft used to repair a blunt trauma femoral artery 
injury 3 day earlier. 
In the aortic group, five of the seven patients (71%) 
had staged axillofemoral (superficial femoral In =3], 
deep femoral [n=2]) bypass with 9 mm ringed PTFE 
graft, using the lateral to the sartorius surgical ap- 
proach, and crossover reversed saphenous vein 
femorofemoral grafts with excision of the aortic grafts 
24-48 h later (Fig. 2). In all patients with aortic graft 
infections, the aortic stump was closed in two layers 
with polypropylene sutures and reinforced with an 
omental tongue. The retroperitoneum was widely de- 
brided of all necrotic tissue and widely drained with 
closed suction drainage until the cultures of the fluid 
drained remained negative for longer than 5-7 days. 
Two patients had  synchronous aortobifemoral graft 
excision and revascularisation with a neo-aorto- 
iliofemoral system using all superficial femoral vein 
in one patient and combining superficial femoral vein 
and contralateral saphenous vein graft in the other 
patient (Fig. 3). The other nine patients with infra- 
inguinal graft infections required simultaneous ex- 
cision of the prosthetic graft and saphenous vein 
revascularisation (Table 2). All patients required ex- 
tensive debridement ofnecrotic tissue and closed suc- 
tion drainage. In two patients, rotational coverage with 
the sartorius muscle was needed. All patients were 
Table 1. Clinical characteristics and outcome of patients with Staphylococcus aureus 
infection of aortobifemoral grafts. 
Case Time of Follow-up 
number Age (years) presentation Procedure (months) 
1 68 48 months Staged Ax-fem (PTFE) Alive and well 
Fern-fern (SV) (20 months) 
Excision infected ABF 
2 73 5 months Staged Ax-fem (PTFE) Expired 
Fern-fern (SV) (13 months) 
Exc Inf ABF 
3 51 6 months Staged Ax-fem (PTFE) Alive and well 
Fern-fern (SV) (31 months) 
Exc inf ABF 
4 74 1 month Staged Ax-fem (PTFE) Expired 
Fem-fem (SV) (3 months) 
Exc inf ABF 
5 57 36 months Simultaneous exc ABF Alive and well 
NAIS (SEV) (13 months) 
6 49 8 months Simultaneous exc ABF Alive and well 
NAIS (SFV-SV) (37 months) 
7 66 24 months Staged Ax-fem (PTFE) Expired 
Fern-fern (SV) (19 months) 
Exc inf ABE 
Ax-fem-Axillofemoral; ABF=Aortobifemoral; SV=saphenous vein; NAIS=Neo- 
aortoiliac system; SFV = superficial femoral vein. 
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Fig. 2. Postoperative arteriogram 6 months after staged axillosuperficial femoral (A and B) and crossover femorofemoral vein graft (C) 
24 h prior to total excision of the infected aortic graft in Fig. 1. 
A B 
Fig. 3. Postoperative arteriogram (6 months) of the two patients who underwent simultaneous infected aortic graft excision and in-line 
aortofemoral autogenous superficial femoral vein bypass (A) and combined superficial femoral vein (large arrow) and saphenous vein 
(B) (small arrow). 
treated with intravenous vancomycin for 6 weeks 
using a basilic or subclavian line for home antibiotic 
therapy. 
Because of the small number of patients, as well as 
the heterogeneity of the groups, no statistical analysis 
between the groups was performed. Actual survival, 
pr imary patency and limb salvage were calculated 
with standard methods. 
Results 
Recent follow-up data was obtained in 15 patients 
(94%), with one patient lost to follow-up 23 months 
after surgery. The mean follow-up for the 16 patients 
was 24.4 months (range 3-81 months). There were no 
in-hospital mortalities in this series. There were four 
late deaths (25%) in the 16 patients. Three (43%) of 
the patients with aortic graft infections died during 
the follow-up period. Two died at 3 and 13 months of 
cardiac causes and the third patient of an unknown 
cause at 19 months. In the infrainguinal graft infection 
group of nine patients, one patient (11%) died at 16 
months of follow-up from metastatic bladder car- 
cinoma. None of the 16 patients required amputation 
during the follow-up period. Three (25%) of the 12 
alive patients have moderate lower extremity clau- 
dication due to superficial femoral artery disease. Two 
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Table 2. Clinical characteristics and outcome of patients with Staphylococcus aureus infrainguinal graft infections. 
Case Age Time of Follow-up 
number (years) Initial procedure presentation Procedure (months) 
8 58 Crossover fem-fem (PTFE) 2 weeks  Simultaneous excision of Alive and well 
graft, fern-fern (SV) (11 months) 
9 26 Ipsilateral fem-fem 3 days Simultaneous exc. of Alive and well 
(Dacron) graft, fem-fem (SV) (5 months) 
10 56 Ax-fem, fern-fern (PTFE) 1 week Simultaneous exc. of Expired 
graft, fem-fem (SV) (6 months) 
11 67 Fem-BK-pop (PTFE) 4 weeks Simultaneous exc.of Alive and well 
graft, fern-AT (SV) (22 months) 
12 79 Fem-BK-pop (PTFE) 10 weeks  Simultaneous exc.of Alive and well 
graft, fem-PT (SV) (67 months) 
13 79 Fem-AK-pop (PTFE) 4 weeks  Simultaneous exc.of Alive and well 
graft, fem-at (SV) (7 months) 
14 89 Fem-PT (PTFE-Miller cuff) 2 weeks Simultaneous exc.of Alive and well 
graft, fern-AT (SV) (81 months) 
15 57 Fem-BK-pop (PTFE) 25 weeks Simultaneous exc.of Alive and well 
graft, fem-PT (SV) (11 months) 
16 66 Fem-PT (PTFE-Miller cuff) 6 weeks Simultaneous exc.of Alive and well 
graft, fern-AT (SV) (38 months) 
Ax-fem = axillofemoral; BKpop = below-knee popliteal; AK pop = above-knee popliteal; SV = saphenous vein; PT = posterior 
tibial artery; AT = anterior tibial artery. 
(28%) of the seven patients with oxillofemoral, 
femorofemoral reconstruction for infected aortic grafts 
developed complications related to the reconstruction. 
One patient had recurrent thrombosis of the crossover 
saphenous vein femorofemoral bypass requiring con- 
version to bilateral axillo-deep femoral bypass grafting 
at 4 weeks. This patient expired, free of infection, 12 
months later from a myocardial infarction. The other 
patient had disruption of the axillary portion of the 
axillofemoral bypass graft 3 weeks post-surgery re- 
quiring successful repair and thrombectomy. This 
same patient developed occlusion 5 months later of 
the crossover saphenous vein femorofemoral bypass 
which required conversion to a PTFE femorofemoral 
bypass. This patient is alive and infection-free 13 
months later. The nine patients with infrainguinal 
prosthetic graft infections have had no problems with 
the autogenous vein reconstruction and are also in- 
fection-free during the follow-up period. 
The primary patency at 30 days and 36 months for 
the aortic graft infection group was 86% and 70%, 
respectively. No limbs have been lost for either group. 
The patient survival at 30 days and 36 months for 
the aortic graft infection group was 100% and 56%, 
respectively (Fig. 4). In the infrainguinal graft infection 
group the primary patency has remained at 100% with 
a mean follow-up of 27.1 months (range 5-81 months). 
The 30-day and 5-year survival for this group was 
100% and 89%, respectively (Fig. 5). 
Discussion 
The challenge that a vascular surgeon has in the pres- 
ence of a vascular graft infection can be overwhelming. 
The diagnosis can be difficult in some cases of sepsis 
in a patient with an aortic graft. Similarly, the strategy 
to eradicate the infection and provide adequate lower 
extremity revascularisation has been controversial. 
Even though most series agree that complete graft 
excision and alternate route revascularisation is op- 
timal, some authors have proposed prosthetic graft 
preservation in selected cases of graft infection. 13'2s 
Other authors have reported good results with either 
in-line autologous vein reconstruction 1'~6'2°-= or auto- 
genous femorofemoral graft combined with prosthetic 
axillo-deep femoral or superficial femoral grafts. 1-2° We 
have adopted this approach in selected cases of graft 
infections in which we felt the bacteriology of the 
infection was amenable to graft excision with auto- 
genous vein revascularisation a d antibiotic therapy. 
Although S. aureus has been considered a moderately 
virulent organism in animal and in vitro models,  24-26 
various clinical series have demonstrated that auto- 
genous vein can resist infection and heal in a con- 
taminated field if wide debridement, closed suction 
drainage and long-term antibiotic therapy is in- 
stituted.l,5,16, 20-22 
The lack of in-hospital mortality in our 16 patients 
can be attributed to a strict adherence to the basic 
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Fig. 4. Actual survival limb salvage and primary patency in patients with aortic graft infections (n= 7). ( 
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Fig. 5. Actual survival, imb salvage and primary patency in patients with infrainguinal graft infections (n = 9). ( ) Survival; (---) 
limb salvage; (...) primary patency. 
principles of patient stabilization, complete infected 
graft excision with wide debridement and either staged 
or simultaneous revascularisation with autogenous 
vein and long-term intravenous antibiotic therapy. The 
small cohort of patients, as well as the heterogeneity 
of the therapeutic strategies described in this study, 
makes it difficult to propose a specific strategy of 
the best configuration of autogenouss vein re- 
vascularisation, but it definitely suggests the advant- 
age of the policy of autogenous vein reconstruction. 
The disadvantage of the prosthetic axillo-deep fem- 
oral (or superficial femoral) and combined saphenous 
vein femorofemoral bypass graft is recurrent hrom- 
bosis either because of the length of the prosthetic 
graft, the possible compression of the axillo-deep fem- 
oral graft, or inadequate size of the saphenous vein 
for the femorofemoral bypass grafts. We encountered 
this complication in two (28%) of seven patients with 
aortic graft infections. The failures of the saphenous 
vein crossover bypass grafts were due to inadequate 
size in one patient and the development of intimal 
hyperplasia (5 months later), probably induced by 
a previous thrombectomy. We currently'recommend 
preoperative duplex assessment of the size of the 
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saphenous and superficial femoral vein prior to se- 
lecting the operative strategy. Postoperative duplex 
scan surveillance of the saphenous vein is mandatory 
because the long-term failure rate from intimal hy- 
perplasia can be significant and early detection can 
retrieve a failing graft. 27 
Two (28.5%) of patients with aortic graft infections 
had simultaneous graft excision and lower extremity 
revascularisation with a neo-aortoiliac system using 
superficial femoral vein alone or in combination with 
saphenous vein. This technique has shown excellent 
results in two large recent series reported. 5"22 We feel 
that in selected patients this technique offers multiple 
advantages that avoid extra-anatomic prosthetic graft 
revascularisation with its attendant risk for infection 
and recurrent thrombosis. Longer-term follow-up will 
be needed to establish the role of this innovative 
technique in the management of these very sick and 
challenging patients. 
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